COVID-19 susceptibility in long-term care facilities

Melissa K. Andrew; Lisa Barrett

doi:10.1016/S2666-7568(21)00119-7

COVID-19 susceptibility in long-term care facilities

Melissa K. Andrew, Lisa Barrett

Medicine

Research output: Contribution to journal › Comment/debate › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	e310-e311
Journal	The Lancet Healthy Longevity
Volume	2
Issue number	6
DOIs	https://doi.org/10.1016/S2666-7568(21)00119-7
Publication status	Published - Jun 2021

Bibliographical note

Funding Information:
MKA reports grants from the Canadian Frailty Network, Canadian Institutes of Health Research, Public Health Agency of Canada, Sanofi, Pfizer, and GlaxoSmithKline, and personal fees from Pfizer, Sanofi, and Seqirus, outside the submitted work. LB reports grants from CIHR, the Canadian COVID Immunity Task Force, Gilead, ViiV, Abbvie, Merck, and honoraria for advisory activities from Gilead, ViiV, Abbvie, and Merck outside the submitted work.

ASJC Scopus Subject Areas

Geriatrics and Gerontology
Family Practice
Psychiatry and Mental health
Health(social science)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S2666-7568(21)00119-7

Cite this

@article{3fe7ed4229c944c88884583d413a9944,

title = "COVID-19 susceptibility in long-term care facilities",

author = "Andrew, {Melissa K.} and Lisa Barrett",

note = "Funding Information: MKA reports grants from the Canadian Frailty Network, Canadian Institutes of Health Research, Public Health Agency of Canada, Sanofi, Pfizer, and GlaxoSmithKline, and personal fees from Pfizer, Sanofi, and Seqirus, outside the submitted work. LB reports grants from CIHR, the Canadian COVID Immunity Task Force, Gilead, ViiV, Abbvie, Merck, and honoraria for advisory activities from Gilead, ViiV, Abbvie, and Merck outside the submitted work.",

year = "2021",

month = jun,

doi = "10.1016/S2666-7568(21)00119-7",

language = "English",

volume = "2",

pages = "e310--e311",

journal = "The Lancet Healthy Longevity",

issn = "2666-7568",

publisher = "Elsevier Ltd.",

number = "6",

}

TY - JOUR

T1 - COVID-19 susceptibility in long-term care facilities

AU - Andrew, Melissa K.

AU - Barrett, Lisa

N1 - Funding Information: MKA reports grants from the Canadian Frailty Network, Canadian Institutes of Health Research, Public Health Agency of Canada, Sanofi, Pfizer, and GlaxoSmithKline, and personal fees from Pfizer, Sanofi, and Seqirus, outside the submitted work. LB reports grants from CIHR, the Canadian COVID Immunity Task Force, Gilead, ViiV, Abbvie, Merck, and honoraria for advisory activities from Gilead, ViiV, Abbvie, and Merck outside the submitted work.

PY - 2021/6

Y1 - 2021/6

UR - http://www.scopus.com/inward/record.url?scp=85107835589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85107835589&partnerID=8YFLogxK

U2 - 10.1016/S2666-7568(21)00119-7

DO - 10.1016/S2666-7568(21)00119-7

M3 - Comment/debate

AN - SCOPUS:85107835589

SN - 2666-7568

VL - 2

SP - e310-e311

JO - The Lancet Healthy Longevity

JF - The Lancet Healthy Longevity

IS - 6

ER -

COVID-19 susceptibility in long-term care facilities

Bibliographical note

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Cite this